Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New sedative may offer safer procedures for elderly and frail patients

NCT ID NCT07362173

First seen Jan 25, 2026 · Last updated May 22, 2026 · Updated 14 times

Summary

This study tests a new sedative called remimazolam in 200 elderly or very ill patients (age 65+, serious health conditions) undergoing medical procedures like endoscopy. The goal is to see if it provides safer sedation with fewer drops in blood pressure or breathing problems compared to standard sedatives. The drug is designed to work quickly and wear off fast, which may be especially helpful for high-risk patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD III/IV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Regional Institute of Gastroenterology-Hepatology Prof. Dr. Octavian Fodor

    Cluj-Napoca, Cluj, Romania

Conditions

Explore the condition pages connected to this study.